Advertisement
Advertisement

QNRX

QNRX logo

Quoin Pharmaceuticals, Ltd. - ADR

6.49
USD
Sponsored
+0.19
+3.02%
Apr 15, 15:59 UTC -4
Closed
exchange

Pre-Market

6.48

-0.01
-0.15%

Quoin Pharmaceuticals, Ltd. - ADR Profile

About

Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare and orphan diseases. Quoin Pharmaceuticals, formerly known as Cellect Biotechnology Ltd., is based in Tel Aviv.

Info & Links

CEO

Michael Myers

Headquarters

42127 Pleasant Forest Court
Ashburn, VA 20148, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

https://quoinpharma.com

Auditor

Marcum LLP

Share holders

7

Employees

5

Quoin Pharmaceuticals, Ltd. - ADR Statistics

Valuation Measures

Market Capitalization2

11.69M

Enterprise Value

9.86M

Enterprise Value/EBITDA(ttm)

-0.70

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.37

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-535.00%

Return on Invested Capital(ttm)

82.72%

Return on Assets(ttm)

-223.99%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-14.08M

Net Income Available to Common(ttm)

-13.77M

Diluted EPS(ttm)

-34.29

Share Statistics

Beta (5Y Monthly)

1.61

52-Week Change

10.56%

S&P 500 52-Week Change

33.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

838.98K

Dividend Yield

0.00%

Float4

726.00K

% Held by Insiders

13.46%

% Held by Institutions

8.63%

Balance Sheet

Total Cash(mrq)

5.41M

Total Cash Per Share(mrq)

6.45

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.61%

Quick Ratio(mrq)

3.61%

Book Value Per Share(mrq)

51.32

Cash Flow

Operating Cash Flow Per Share(ytd)

-12.68

Free Cash Flow(ytd)

-13.54M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement